Indiana Palliative Excellence in Alzheimer’s Care Efforts (IN-PEACE): Protocol for a randomized controlled trial in persons with advanced dementia

医学 卓越 痴呆 随机对照试验 缓和医疗 协议(科学) 老年学 家庭医学 护理部 替代医学 疾病 外科 内科学 病理 政治学 法学
作者
Laura R. Holtz,Kurt Kroenke,Sujuan Gao,Susan E. Hickman,Alexia M. Torke,Nina M. Johnson,A. L. Pemberton,Andrea Vrobel,Minmin Pan,Greg A. Sachs
出处
期刊:Contemporary Clinical Trials [Elsevier]
卷期号:130: 107217-107217 被引量:2
标识
DOI:10.1016/j.cct.2023.107217
摘要

Dementia affects 6.5 million persons in the U.S., a number which is expected to double by 2060. More than half of persons with dementia die at home, creating an enormous burden for both patients and caregivers. However, there is a paucity of research on community-based palliative care interventions for advanced dementia. The Indiana Palliative Excellence in Alzheimer's Care Efforts (IN-PEACE) study is a randomized trial to test the effectiveness of a collaborative predominantly telehealth home-based intervention for persons with advanced dementia residing in the community and their primary, informal caregivers. The primary aim is to determine if this palliative care focused supportive intervention is superior to usual care in reducing neuropsychiatric symptoms of dementia. Secondarily, intervention effects on other patient symptoms (e.g., pain), caregiver distress and depression, and emergency department (ED)/hospitalization events are examined. The study population consists of participant pairs comprising a person with dementia and their primary, informal caregiver. The person with dementia must be ≥65 years old, with a clinical diagnosis of moderate to severe dementia. A total of 201 demographically and socioeconomically diverse participant pairs have been randomized to the IN-PEACE care coordination intervention (n = 99) or usual care (n = 102). Outcome assessments are conducted at baseline, and quarterly for up to 2 years (3, 6, 9, 12, 15, 18, 21, and 24 months). IN-PEACE results will inform care for the large number of individuals with advanced dementia residing in the community and enable informal caregivers to provide effective home-based care. Trial registration: clinicaltrials.gov Identifier: NCT03773757.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
超级万声完成签到,获得积分10
1秒前
Ava应助浮世采纳,获得10
2秒前
2秒前
5秒前
武紫安完成签到,获得积分10
5秒前
Da-ming发布了新的文献求助10
6秒前
深情映冬发布了新的文献求助10
6秒前
程程程完成签到,获得积分10
8秒前
987654完成签到,获得积分10
9秒前
搜集达人应助乘一采纳,获得10
9秒前
11秒前
11秒前
研友_Z11kkZ完成签到,获得积分10
13秒前
Da-ming完成签到,获得积分10
14秒前
青山随云走完成签到,获得积分10
14秒前
14秒前
555发布了新的文献求助10
15秒前
浮世发布了新的文献求助10
16秒前
17秒前
desperate完成签到 ,获得积分10
18秒前
洪汉完成签到,获得积分10
19秒前
田田完成签到,获得积分10
19秒前
科研張应助小王采纳,获得20
19秒前
野子发布了新的文献求助10
20秒前
21秒前
顾矜应助kento采纳,获得50
22秒前
cxx完成签到 ,获得积分10
22秒前
22秒前
23秒前
赵坤煊完成签到 ,获得积分10
24秒前
英俊的铭应助科研通管家采纳,获得10
25秒前
酷波er应助科研通管家采纳,获得10
25秒前
脑洞疼应助科研通管家采纳,获得10
25秒前
小马甲应助科研通管家采纳,获得10
25秒前
25秒前
NexusExplorer应助科研通管家采纳,获得10
25秒前
丘比特应助科研通管家采纳,获得10
25秒前
科研通AI2S应助科研通管家采纳,获得10
25秒前
26秒前
26秒前
高分求助中
The Oxford Handbook of Social Cognition (Second Edition, 2024) 1050
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 500
COSMETIC DERMATOLOGY & SKINCARE PRACTICE 388
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3141401
求助须知:如何正确求助?哪些是违规求助? 2792423
关于积分的说明 7802495
捐赠科研通 2448598
什么是DOI,文献DOI怎么找? 1302633
科研通“疑难数据库(出版商)”最低求助积分说明 626650
版权声明 601237